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Objective. The objective of this work was to study the risk factors of ischaemic heart disease (IHD) in rural populations of the
Nilgiris, south India, with stress on the various social habits and oxidant stress. Methods. A total of 72 patients with cardiovascular
disease (CVD) and 12 healthy volunteers were screened. Forty-seven patients with CVD (intervention group) and 10 healthy
volunteers (control group) were randomly selected for the study. Written informed consent was obtained from all the participants,
and their demographic details were collected. A 6mL blood sample was collected from each of the participants, and the serum
was separated in the samples. The levels of enzymic (superoxide dismutase, catalase) and nonenzymic antioxidants (ascorbic
acid) in the plasma were determined biochemically. The level of thiobarbituric acid species (TBARS), which is a predictor of
lipid peroxidation, was measured. Results. The participants of the study were stratiﬁed as according to demographic and social
variables. The values of all the antioxidants and TBARS were statistically compared. Signiﬁcantly reduced antioxidant levels and
increased TBARS levels were found in the intervention group compared with the control group. The results suggest that the
lowered antioxidant level may be a result of the oxidant stress of the disease. Statistically signiﬁcant diﬀerences were not found in
the antioxidant and TBARS levels when comparing smokers versus nonsmokers, alcoholics versus nonalcoholics, and vegetarians
versus nonvegetarians. Conclusion. The major causes of CVD amongst the rural populations of the Nilgiris, south India, are
preventable causes such as smoking and high fat intake, all of which cause oxidative stress, as seen in our study through various
serum markers.
1.Introduction
India has one of the highest burdens of cardiovascular
diseases (CVDs). The prevalence of cardiovascular disease
(CVD) in rural India is 7.4%, and in urban India, it is
11% [1]. The incidence of ischaemic heart disease (IHD)
and coronary heart disease (CHD) is steadily increasing
in the Indian subcontinent. According to World Health
Report 2002, CVD will be the largest cause of death in
India by 2020. It is predicted that 2.6 million Indians will
die due to CHD. This number will represent 54.1% of
all CVD deaths in the age group of 30–69 years [2]. The
incidence of CHD in urban India is increasing steadily at
a rapid pace. Although many studies have been carried
out in urban populations, very few studies have examined
the etiologic factors in rural Indian populations. IHD is a
progressive disease arising when the supply of oxygen in
the myocardium is compromised by impeded blood ﬂow in
the coronary vasculature caused by luminal occlusion. IHD
leads to the development of atherosclerosis and hypertrophy
of musculature. The pathogenesis of atherosclerosis involves
damage to the capillary endothelium caused by various
factors including oxidized low-density lipoprotein (LDL)
[3, 4]. Muscular hypertrophy is caused by elaboration
of local elaboration of growth factors from surrounding
macrophages which are primed by free radicals. The plaque
formed thereupon is covered by thinned out intima and
media. A luminal compromise of nearly 70% is needed to
producesymptomaticIHD.Freeradicalsarechemicalspecies
that can be considered as fragments of molecules possessing
unpaired electrons. They are generally very reactive [5],
and they are produced continuously in cells either as2 ISRN Pharmacology
by-products of metabolism or during phagocytosis [6]. The
major types of free radicals found in biological systems are
reactive oxygen species (ROS) and reactive nitrogen species
(RNS) [7]. Free radicals are produced mainly by cellular and
environmental sources. They are generated by absorption of
radiant energy, endogenous oxidative reactions, enzymatic
metabolism of exogenous chemicals, and generation of free
radicals in pathogenic conditions [8]. The present study was
planned and conducted to evaluate the role of oxidative
stress in patients with CVD patients from populations of the
Nilgiris, south India, and the role of antioxidants in patients
with IHD patients and to assess the classical risk factors
associated with the oxidative stress related to CVD.
2.MaterialsandMethods
An open randomized control study was conducted at the
Government District Headquarters Hospital, Ootacamund,
Nilgiris District, Tamil Nadu, India, over 10 months. A
total of 72 patients with CVD and 12 healthy volunteers
were screened for the study. The study was carried out
for 10 months from May 2005 to February 2006. The
study was approved by the Institutional Ethics Committee,
J.S.S. College of Pharmacy, Ootacamund, and the study
was performed according to the recommendations of the
Declaration of Helsinki.
The study was conducted on patients (31–80 years)
suﬀering from CVD, such as, IHD, myocardial infarction
(MI) or unstable angina (UA), who were admitted in the
Intensive Cardiac Care Unit (ICCU)/Intensive Care Unit
(ICU) of the Government District Headquarters, Ootaca-
mund. IHD patients with chronic diseases such as diabetes
and hypertension and those who had suﬀered strokes were
excluded. Pregnant women and lactating mothers were also
excluded from the study.
Forty-seven patients in the 31–80 year age group and
10 healthy volunteers in the 31–40 year age group were
included in the intervention and control groups, respec-
tively. These subjects were selected randomly without any
sex predisposition. The subjects or their guardians were
interviewed for 15–20 minutes, and their demographic
details were collected. The demographic details included
primary patient information (such as name, age, and sex),
socioeconomic status and food habituation. After enrolment
as a study participants, the history was collected through
a structured enrolment form, the medical records (case
history of patients) which included the age, gender, in-
patient number, socioeconomic status, social habits, past
medical, and surgical history.
A6mLfastingbloodsamplewascollectedfromeachpar-
ticipant. The blood samples were centrifuged at 3000RPM
for 20 minutes, and the serum was separated and stored
at −20◦C until analysis. The levels of enzymic (superoxide
dismutase (SOD) [9] and catalase (CAT) [10]) and nonen-
zymic(ascorbicacid[11])antioxidantsandpredictoroflipid
peroxidation as measured by the thiobarbituric acid species
(TBARS) [12] in the serum were determined. Flow diagram
of requirement and allocation of participants and analysis of
the data are given in Figure 1.
The mean ± S E Mv a l u e sw e r ec a l c u l a t e df o re a c hg r o u p .
Signiﬁcant diﬀerence between groups was determined using
one-way ANOVA followed by the Bonferroni test. A P value
less than 0.05 was considered as signiﬁcant.
3. Results
Including the healthy controls 57 subjects were enrolled in
the study. The greatest number of subjects was in the 61–70
year group (20—of which 13 were males and 7 were females)
and51–60yeargroup(16—ofwhich9weremalesand7were
females). In all, there were 33 male subjects (58%) and 24
female subjects (42%) in the intervention group (Table 1).
In our study, 21/30 males and 9/17 females had a BMI
of 21–25kg/m2. No patient had a BMI greater than 30.
Thus none of the patients in the study had obesity as a
predisposing factor. Of the 47 patients, 33 were workers with
an average monthly income of Rs.600. In the intervention
group,26malesubjectsoutof30and7femalesubjectsoutof
17 were workers by occupation. The prevalence of CVD was
highest in this group. This may be due to their habits, such as
heavy smoking and having a high alcohol intake and high
consumption of animal fat. In the control group, most of
the subjects were vegetarians, nonsmokers and nonalcoholic
subjects. Most of the male subjects in the intervention group
were nonvegetarians, smokers, and alcoholics (Table 2).
The levels of enzymic and nonenzymic antioxidants
of the patients with CVD were evaluated after the initial
symptomatic management was done. The mean value of
SODlevelsinhealthyparticipantswasfoundtobe2.15±0.01
units/minute/mg protein. In patients with CVD, a signiﬁcant
reduction (P<0.001) in SOD levels was observed, compared
with healthy control participants. The SOD levels observed
in patients with IHD, MI, and UA were 1.05 ± 0.01, 1.54 ±
0.01 and 1.86 ± 0.01, units/minute/mg protein, respectively
(Table 3).
The mean value of catalase in healthy participants
was found to be 19.33 ± 0.81µmoles of H2O2 con-
sumed/minute/mg protein. In patients with CVD, a sig-
niﬁcant reduction (P<0.001) in the catalase values was
observed compared with healthy control participants. The
catalase levels observed in patients with IHD, MI, and UA
were 6.01±0.45, 6.73±0.14, and 6.28±0.08µmoles of H2O2
consumed/minute/mg protein, respectively.
The normal mean value of ascorbic acid was found to be
139.20 ± 10.08mg/dL. In patients with CVD, a signiﬁcant
reduction (P<0.001) in the ascorbic acid values was
observed when compared with the control participants. The
ascorbic acid levels observed in patients with IHD, MI,
and UA were 66.60 ± 17.32, 57.92 ± 10.17, and 71.90 ±
9.73mg/dL, respectively. The estimated level of antioxidants
in the intervention group was lower than that in the control
group. The results of the present investigation suggest that
the lowered level of antioxidants may be a result of the
oxidative stress of the disease. Individual comparisons of
ascorbic acid levels showed that the diﬀerences between
smoker versus nonsmokers, alcoholics versus nonalcoholics
and vegetarians versus nonvegetarians were not statistically
signiﬁcant (Tables 4, 5,a n d6).ISRN Pharmacology 3
Assessed for eligibility
(72 patients and 12 healthy subjects)
Excluded (n = 27)
• Not meeting inclusion criteria (n = 17)
￿ Declined to participate (n = 4)
￿ Other reasons (n = 6)
Enrolment
Randomized (n = 57)
Allotment of control group (n = 10)
￿ Received allotted intervention (n = 10)
￿ Did not receive allotted intervention (n = 0)
Allotment of intervention group (n = 47)
￿ Received allotted intervention (n = 47)
￿ Did not receive allotted intervention
Allocation
and nonenzymic antioxidants were
estimated using blood plasma
Investigation of enzymic and nonenzymic antioxidants
in the plasma were estimated
￿ Lost to follow-up (n = 0) ￿ Lost to follow-up (n = 0)
Analysed (n = 10)
￿ Excluded from analysis (n = 0)
Analysed (n = 47)
￿ Excluded from analysis (n = 0)
Analysis
￿ 6 mL of blood was collected and enzymic
￿ 6 mL of blood was collected and the levels
Figure 1: Requirement, allocation, and follow-up of participants.
Table 1: Categorization of subjects based on age group.
Age group (years)
Subjects
Control group (normal) Intervention group
IHD MI UA
Male Female Male Female Male Female Male Female
31–40 3 7 2 0 1 0 0 0
41–50 0 0 2 1 2 0 0 1
51–60 0 0 4 3 1 1 4 3
61–70 0 0 7 6 5 0 1 1
71–80 0 0 0 0 1 1 0 0
T o t a l 1 0 2 51 21 0
IHD: ischaemic heart disease; MI: myocardial infarction; UA: unstable angina.
Table 2: Categorization of subjects based on social habits.
Gender Diet Smoking habits Alcohol intake
Vegetarian Nonvegetarian Smoking Nonsmoking Alcoholic Nonalcoholic
Male
N3 0 0 3 0 3
CVD 1 29 28 2 12 18
Female
N7 0 0 7 0 7
CVD 4 13 0 17 0 17
Total 15 42 28 29 12 45
N: normal; CVD: cardiovascular disease.4 ISRN Pharmacology
Table 3: Levels of antioxidants and lipid peroxidase in healthy control and patients with CVD.
Subjects enrolled SOD Catalase TBARS Ascorbic acid





Normal (n = 10) 2.15 ±0.01 19.33 ±0.81 68.70 ±6.73 139.20 ±10.08
IHD (n = 25) 1.05 ±0.01∗∗∗ 6.01 ±0.45∗∗∗ 170.16 ±41.12 66.60 ±17.32∗
MI (n = 12) 1.54 ±0.01∗∗∗ 6.73 ±0.14∗∗∗ 204.92 ±24.52 57.92 ±10.17∗
UA (n = 10) 1.86 ±0.01∗∗∗ 6.28 ±0.08∗∗∗ 170.70 ±19.23 71.90 ±9.73
IHD, ischaemic heart disease; MI, myocardial infarction; UA, unstable angina.
Values are mean ± SEM.
∗P<0.05; ∗∗∗P<0.001 compared with control. One-way ANOVA followed by Bonferroni test.
Table 4: Levels of antioxidants and lipid peroxidase in patients ischaemic heart disease based on social habits.
Social habits SOD Catalase TBARS Ascorbic acid





Smoker (n = 18) 1.03 ±0.03 6.077 ±0.44 181.53 ±35.51 66.27 ±20.54
Nonsmoker (n = 7) 1.11 ±0.05 5.90 ±0.47 156.70 ±42.80 67.00 ±11.98
Alcoholic (n = 6) 1.02 ±0.05 5.79 ±0.40 176.83 ±41.24 60.66 ±12.07
Nonalcoholic (n = 19) 1.01 ±0.01 6.08 ±0.45 168.05 ±41.97 68.42 ±18.55
Vegetarian (n = 2) 1.18 ±0.01 6.35 ±0.49 198.51 ±23.33 53.51 ±12.12
Nonvegetarian (n = 23) 1.04 ±0.04 5.98 ±0.46 167.69 ±41.71 67.69 ±17.61
Values are mean ± SEM.
Table 5: Levels of antioxidants and lipid peroxidase in patients with myocardial infarction according to social habits.
Social habits SOD Catalase TBARS Ascorbic acid





Smoker (n = 6) 1.50 ±0.02 6.68 ±0.17 214.16 ±22.60 51.83 ±11.05
Nonsmoker (n = 6) 1.56 ±0.01 6.77 ±0.10 195.62 ±24.50 64.00 ±14.04
Alcoholic (n = 4) 1.49 ±0.02 6.72 ±0.22 210.58 ±25.60 53.75 ±11.61
Nonalcoholic (n = 8) 1.56 ±0.02 6.73 ±0.10 202.11 ±22.10 60.00 ±9.47
Vegetarian (n = 1) 1.60 ±0.03 6.58 ±0.12 186.00 ±20.20 55.01 ±12.32
Nonvegetarian (n = 11) 1.53 ±0.03 6.74 ±0.14 206.62 ±24.90 58.18 ±10.62
Values are mean ± SEM.
Table 6: Levels of antioxidants and lipid peroxidase in patients with unstable angina according to social habits.
Social habits SOD Catalase TBARS Ascorbic acid





Smoker (n = 4) 1.82 ±0.01 6.23 ±0.07 188.25 ±8.62 74.25 ±13.45
Nonsmoker (n = 6) 1.88 ±0.02 6.31 ±0.07 159.00 ±14.50 70.33 ±7.39
Alcoholic (n = 2) 1.82 ±0.01 6.28 ±0.05 182.00 ±17.07 80.5 ±4.94
Nonalcoholic (n = 8) 1.86 ±0.03 6.28 ±0.09 157.87 ±20.55 69.75 ±9.58
Vegetarian (n = 2) 1.90 ±0.01 6.37 ±0.02 177.50 ±16.26 85.50 ±5.14
Nonvegetarian (n = 8) 1.84 ±0.02 6.26 ±0.07 169.00 ±20.52 68.50 ±7.42
Values are mean ± SEM.ISRN Pharmacology 5
The normal mean value of TBARS was found to be
68.70±6.73µmolesofmalondialdehyde/dLserum.Increased
levels of TBARS were observed in subjects with IHD, MI,
and UA, but the results were not statistically signiﬁcant. The
increased TBARS levels may be a result of the oxidant stress
of the disease. Individual comparisons of the TBARS level
between smokers versus nonsmokers, alcoholics, versus non-
alcoholics and vegetarians versus non-vegetarians showed
that the diﬀerences were not statistically signiﬁcant (Tables
4, 5,a n d6).
4. Discussion
To evaluate the oxidative stress and antioxidant status in
patients with CVD in a rural Indian population, a cross-




in males compared with females of the same age group. The
lower incidence in menopausal and postmenopausal females
is probably due to the protective eﬀect of estrogens. Obesity
was not an important risk factor, as seen in our study. The
presence of other comorbid factors may be responsible for
the oxidant damage caused due to smoking and diabetes.
Earlier studies have suggested that, in both men and women,
diabetes,age,andplasmacholesterollevelswereindependent
predictors of IHD mortality. The prevalence of IHD and
relative mortality risk associated with several risk factors
(age, marital status, education, cigarette smoking, systolic
blood pressure, cholesterol, fasting plasma glucose, and
obesity) diﬀer with sex [13, 14].
When the mean values of the serum enzymes were
compared, a marked decrease in the levels of SOD and
catalase was found, whereas the level of TBARS, indicating
lipid peroxidation, was markedly increased. Evaluation of
the serum values in various demographic subsets of the
population was performed, and the greatest changes were
found in smokers, followed by nonvegetarians, suggesting
that smoking has an important role in causing oxidant stress.
Free radicals, cytokines, nitric oxide (NO), and antioxi-
dants play a major role in both atherosclerosis and myocar-
dial damage and preservation [15]. In the present study, it
was found that rural people from the Nilgiris admitted with
IHD, MI, and UA had increased TBARS levels and reduced
SOD, catalase, and ascorbic acid levels. Previous studies have
demonstrated the biological relevance of the antioxidant
defence system to myocardial infarction. Chandra et al.
(1994) demonstrated that there were elevated superoxide
anion, malonyldialdehyde, and glutathione reductase levels
and reduced superoxide dismutase and catalase levels in
unstable angina and acute myocardial infarction cases [16].
Gupta and Chari (2006) measured the levels of proxidants
and antioxidants in patients with IHD and type II diabetes
mellitus. Signiﬁcantly increased levels of malondialdehyde
and decreased levels of superoxide dismutase, glutathione
peroxidase, and vitamin C were found in diabetics without
complications and nondiabetics with IHD compared with
control subjects [17].
ThelevelsofSOD,catalase,andascorbicacidwereshown
to be lower and the TBARS level was shown to be higher
in patients from rural India with IHD, MI, and unstable
angina.Riskfactorssuchasage,beingmale,smoking,alcohol
consumption, a nonvegetarian diet, and occupation played
an important role in the genesis of oxidative stress, which is
one of the causes of CVD.
5. Conclusion
It is concluded on the basis of the present study that free
radicals are implicated in the etiology of CVD and that
enzymatic antioxidants, SOD, and catalase have a major role
in preventing cellular oxidative damage.
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